Lv61
2440 积分 2023-12-20 加入
A mechanism for the initiation of allergen-induced T helper type 2 responses
19天前
已完结
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα
1个月前
已完结
RNA chemistry and therapeutics
1个月前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
1个月前
已完结
First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers
1个月前
已完结
GPCR drug discovery: new agents, targets and indications
1个月前
已完结
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
1个月前
已完结
Fibrosis: cross-organ biology and pathways to development of innovative drugs
2个月前
已完结
Advances in the treatment of systemic lupus erythematosus
2个月前
已完结
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities
2个月前
已完结
皖公网安备34019202002308
